11/25
09:25 am
alur
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence
High
Report
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence
11/20
09:00 am
alur
New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone
High
Report
New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone
11/20
08:07 am
alur
Allurion Technologies (NYSE:ALUR) had its "neutral" rating reaffirmed by analysts at Chardan Capital. They now have a $2.50 price target on the stock.
Medium
Report
Allurion Technologies (NYSE:ALUR) had its "neutral" rating reaffirmed by analysts at Chardan Capital. They now have a $2.50 price target on the stock.
11/18
09:00 am
alur
Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss
Medium
Report
Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss
11/12
04:32 pm
alur
Allurion Technologies Inc (ALUR) Q3 2025 Earnings Call Highlights: Strategic Restructuring and ... [Yahoo! Finance]
High
Report
Allurion Technologies Inc (ALUR) Q3 2025 Earnings Call Highlights: Strategic Restructuring and ... [Yahoo! Finance]
11/12
10:26 am
alur
Allurion Technologies Inc. (ALUR) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Allurion Technologies Inc. (ALUR) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/12
08:00 am
alur
Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update
Medium
Report
Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update
11/11
09:31 am
alur
Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing [Yahoo! Finance]
High
Report
Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing [Yahoo! Finance]
11/11
08:45 am
alur
Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing
High
Report
Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing
11/6
04:05 pm
alur
Allurion to Report Third Quarter 2025 Financial Results on November 12, 2025
Medium
Report
Allurion to Report Third Quarter 2025 Financial Results on November 12, 2025
10/7
08:22 am
alur
Allurion Announces Landmark Peer-Reviewed Publication on Consecutive Use of the Allurion Smart Capsule Showing More Than 20% Weight Loss [Yahoo! Finance]
Medium
Report
Allurion Announces Landmark Peer-Reviewed Publication on Consecutive Use of the Allurion Smart Capsule Showing More Than 20% Weight Loss [Yahoo! Finance]
10/7
08:00 am
alur
Allurion Announces Landmark Peer-Reviewed Publication on Consecutive Use of the Allurion Smart Capsule Showing More Than 20% Weight Loss
Medium
Report
Allurion Announces Landmark Peer-Reviewed Publication on Consecutive Use of the Allurion Smart Capsule Showing More Than 20% Weight Loss
10/1
10:16 am
alur
ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City [Yahoo! Finance]
Low
Report
ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City [Yahoo! Finance]
9/30
04:05 pm
alur
Allurion to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
Low
Report
Allurion to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
9/25
05:35 pm
alur
Medtimo Files Patent Infringement Complaint Against Allurion Technologies [Yahoo! Finance]
Low
Report
Medtimo Files Patent Infringement Complaint Against Allurion Technologies [Yahoo! Finance]